These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3717195)

  • 41. The effect of L-dopa and chlorpromazine on prolactin and growth hormone secretion in normal women.
    Leblanc H; Yen SS
    Am J Obstet Gynecol; 1976 Sep; 126(2):162-4. PubMed ID: 961756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prolactin and the renin-aldosterone axis in human pregnancy.
    Yuen BH; Korn GW
    Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 1):738-40. PubMed ID: 7004189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of perphenazine and bromocriptine on follicular dynamics and endocrine profiles in anestrous pony mares.
    Bennett-Wimbush K; Loch WE; Plata-Madrid H; Evans T
    Theriogenology; 1998 Mar; 49(4):717-33. PubMed ID: 10732080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dynamic evaluation of prolactin secretion with perphenazine in normal and hyperprolactinemic subjects.
    Buckman MT; Peake GT
    Horm Metab Res; 1978 Sep; 10(5):400-8. PubMed ID: 711134
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmacokinetics, pharmacodynamics, and tolerability of cabergoline, a prolactin-lowering drug, after administration of increasing oral doses (0.5, 1.0, and 1.5 milligrams) in healthy male volunteers.
    Andreotti AC; Pianezzola E; Persiani S; Pacciarini MA; Strolin Benedetti M; Pontiroli AE
    J Clin Endocrinol Metab; 1995 Mar; 80(3):841-5. PubMed ID: 7883840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characteristics of prolactin-releasing response to salsolinol (SAL) and thyrotropin-releasing hormone (TRH) in ruminants.
    Hashizume T; Onodera Y; Shida R; Isobe E; Suzuki S; Sawai K; Kasuya E; Nagy GM
    Domest Anim Endocrinol; 2009 Feb; 36(2):99-104. PubMed ID: 19070987
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sedative and cardiorespiratory effects of dexmedetomidine and buprenorphine administered to cats via oral transmucosal or intramuscular routes.
    Santos LC; Ludders JW; Erb HN; Basher KL; Kirch P; Gleed RD
    Vet Anaesth Analg; 2010 Sep; 37(5):417-24. PubMed ID: 20712608
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum prolactin levels following intramuscular chlorpromazine: two- and three-hour response as predictors of six-hour response.
    Busch DA; Fang VS; Meltzer HY
    Psychiatry Res; 1979 Oct; 1(2):153-9. PubMed ID: 45130
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Abscesses following prolonged intramuscular administration of perphenazine enantate.
    Starmark JE; Forsman A; Wahlström
    Acta Psychiatr Scand; 1980 Aug; 62(2):154-7. PubMed ID: 6110312
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chromosome abnormalities in patients treated with chlorpromazine, perphenazine, and lysergide.
    Nielsen J; Friedrich U; Tsuboi T
    Br Med J; 1969 Sep; 3(5671):634-6. PubMed ID: 5811683
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Some endocrine effects of two phenothiazine derivatives, chlorpromazine and perphenazine, in the female mouse.
    JARRETT RJ
    Br J Pharmacol Chemother; 1963 Jun; 20(3):497-506. PubMed ID: 14028829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary excretion of perphenazine and its sulfoxide during administration in oral and long-acting injectable form.
    van Kempen GM
    Psychopharmacologia; 1971; 21(3):283-6. PubMed ID: 5095416
    [No Abstract]   [Full Text] [Related]  

  • 53. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
    Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of dexamethasone on prolactin secretion in late pregnancy.
    Kauppila A; Puukka M; Tuimala R
    Am J Obstet Gynecol; 1979 Aug; 134(7):752-5. PubMed ID: 111552
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of metergoline on serum prolactin stimulated by TRH.
    Iannotta F; Gadaleta G; Pollini C; Vettaro MP
    J Endocrinol Invest; 1980; 3(3):301-3. PubMed ID: 6776182
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional evaluation of prolactin secretion: a guide to therapy.
    Friesen H; Guyda H; Hwang P; Tyson JE; Barbeau A
    J Clin Invest; 1972 Mar; 51(3):706-9. PubMed ID: 4622109
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of dopamine and neuroleptics on plasma growth hormone and prolactin in normal men.
    Langer G; Sachar EJ; Halpern FS
    Psychoneuroendocrinology; 1978 Apr; 3(2):165-9. PubMed ID: 704750
    [No Abstract]   [Full Text] [Related]  

  • 58. Vaginal bromocriptine: pharmacology and effect on serum prolactin in normal women.
    Vermesh M; Fossum GT; Kletzky OA
    Obstet Gynecol; 1988 Nov; 72(5):693-8. PubMed ID: 3173919
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of anaesthetics on basal, perphenazine-induced and thyrotrophin releasing hormone-induced prolactin secretion in ovariectomized, oestrogen-treated rats.
    Lawson DM; Gala RR
    J Endocrinol; 1975 Aug; 66(2):151-7. PubMed ID: 809523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-lasting suppression of prolactin secretion and rapid shrinkage of prolactinomas after a long-acting, injectable form of bromocriptine.
    Montini M; Pagani G; Gianola D; Pagani MD; Salmoiraghi M; Ferrari L; Lancranjan I
    J Clin Endocrinol Metab; 1986 Jul; 63(1):266-8. PubMed ID: 3711262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.